Monday, August 30, 2021

Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19

In an observational study, researchers report that the combination of casirivimab and imdevimab -- two monoclonal antibody treatments under Food and Drug Administration emergency use authorization -- keep high-risk patients out of the hospital when infected with mild to moderate COVID-19.

from Latest Science News -- ScienceDaily https://ift.tt/3gILcnA
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Claude Fable 5 AI finds a tiny formula that topples an 87-year-old math conjecture

A mathematician working at Anthropic says he used the AI model Claude Fable 5 to uncover a remarkably simple counterexample to the Jacobian ...